|Articles|February 1, 2017
- Pharmaceutical Executive-02-01-2017
- Volume 37
- Issue 2
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Region in Reform? Access Pains and Gains in Latin Americaover 8 years ago
CMED: The ‘Curupira’ of Brazil’s Pharma Marketover 8 years ago
The Trouble with Pharma Partnerships ... And How to Fix Themover 8 years ago
Reducing the Risk of Noncomplianceover 8 years ago
When You Need Experts, Use Themover 8 years ago
Pricing Pressures and Policy Changesover 8 years ago
Not Your Typical Pharma Datelineover 8 years ago
Market Access: Current and Future Statesover 8 years ago
Market Access: A UK Perspectiveover 8 years ago
Country Report: SingaporeNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
